News
INGN
10.62
+2.81%
0.29
Cautious Hold Rating on Inogen Amid Mixed Growth Signals and Business Challenges
TipRanks · 19h ago
Needham Reiterates Hold on Inogento Hold
Benzinga · 20h ago
Inogen’s Q4 Revenue Beat Overshadowed by Lack of Guidance, Earning a Hold Rating
TipRanks · 1d ago
Closing Bell Movers: KB Home jumps 7% after Q4 earnings beat
TipRanks · 1d ago
Press Release: Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
Dow Jones · 1d ago
Inogen expects prelim Q4 revenue in the range of $79M to $80M
Seeking Alpha · 1d ago
Inogen raises FY24 revenue view to $334.5M-$335.5M from $329M-$331M
TipRanks · 1d ago
INOGEN INC: SEES FY 2024 REV TO BE IN RANGE $334.5 MLN TO $335.5 MLN
Reuters · 1d ago
INOGEN INC: SEES Q4 2024 REV TO BE IN RANGE OF $79.0 MLN TO $80.0 MLN
Reuters · 1d ago
INOGEN ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2024 REVENUE
Reuters · 1d ago
*Inogen Sees 2024 Rev $334.5M-$335.5M >INGN
Dow Jones · 1d ago
Weekly Report: what happened at INGN last week (0106-0110)?
Weekly Report · 1d ago
Weekly Report: what happened at INGN last week (1230-0103)?
Weekly Report · 01/06 09:19
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device
NASDAQ · 12/31/2024 14:29
BUZZ-Inogen gains after FDA approves airway clearing device
Reuters · 12/30/2024 14:08
Inogen Expands U.S. Market with FDA Clearance
TipRanks · 12/30/2024 13:58
Inogen gets FDA 510(k) clearance for the SIMEOX 200 Airway Clearance Device
TipRanks · 12/30/2024 13:35
INOGEN RECEIVES FDA 510(K) CLEARANCE FOR SIMEOX 200 AIRWAY CLEARANCE DEVICE
Reuters · 12/30/2024 13:30
INOGEN INC - PLANS TO PURSUE LIMITED LAUNCH OF SIMEOX 200 IN 2025
Reuters · 12/30/2024 13:30
Weekly Report: what happened at INGN last week (1223-1227)?
Weekly Report · 12/30/2024 09:18
More
Webull provides a variety of real-time INGN stock news. You can receive the latest news about Inogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About INGN
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.